Article Sidebar

Download
PDF

Main Article Content

Abstract

ABSTRACT
Shighella spp is a Gram-negative bacillus belonging to the Enterobacteriaceae family. It is most often responsible for diarrhoea in children under 5 years of age and also in adults. The uncontrolled use of antibiotics has led to the development of resistant strains that pose a threat to public health. This resistance of strains associated with genetic diseases such as trisomy 21 can cause huge management problems. This report relates the first case of sighellosis in Senegal with multi-resistant Shigella spp in a child with trisomy 21.

RÉSUMÉ
Shighella spp est un bacille gram négatif de la famille des entérobactéries. Il provoque le plus souvent des diarrhées chez l'enfant de moins de cinq ans et chez les adultes. L’usage incontrôlé des antibiotiques est à l’origine du développement de souches résistantes qui posent déjà un problème santé publique. Ces souches résistantes posent encore plus de problèmes de prise en charge chez les sujets avec des troubles g anomalies génétiques ou chromosomiques. Nous reportons le premier cas de shigelose spp mulirésistante chez un enfant sénégalais trisomique.

Keywords

Shigella spp ESBL resistant strain Trisomy 21

Article Details

How to Cite
Diakhaby, M. E. B., Ba, A., Gueye, O., Ndour, D., Diouf, S., & Toure Kane, C. (2021). Extended-Spectrum Beta-Lactamase Secreting Shigella Spp Strains Isolated From a Senegalese Child with Trisomy 21. HEALTH SCIENCES AND DISEASE, 22(6). https://doi.org/10.5281/hsd.v22i6.2775
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. https://www.pasteur.fr/fr/centre-medical/fiches-maladies/shigellose (consulted at May, 11th 2020)
  2. Kazi A, Hisyam Ismail CMK, Anthony AA, Chuah C, Leow CH, Lim BH, Leow CY. (2020). Conception et évaluation d'un vaccin recombinant chimérique ciblant les anticorps codant pour les antigènes de la membrane externe de Shigella flexneri. Infection, génétique et évolution, 80, 104176. doi: 10.1016 / j.meegid.2020.104176
  3. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down’s syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002; 359:1019–25.
  4. Canfield MA, Honein MA, Yuskiv N, Xing J, Mai CT, Collins JS. National estimates and race/ethnic-specific variation of selectedbirth defects in the United States, 1990–2001. Birth Defects Res AClin Mol Teratol 2006; 76:747–56.
  5. Turner S, Sloper P, Cunningham C, Knussen C. Health problems inchildren with Down’s syndrome. Child Care Health Dev 1990;16:83–97
  6. Burgio GR, Ugazio AG, Nespoli L, Marcioni AF, Bottelli AM,Pasquali F. Derangements of immunoglobulin levels, phytohemag-glutinin responsiveness and T and B cell markers in Down’ssyndrome at different ages. Eur J Immunol 1975; 5:600–3.
  7. Burgio GR, Lanzavecchia A, Maccario R, Vitiello A, Plebani A,Ugazio AG. Immunodeficiency in Down’s syndrome: T lympho-cyte subset imbalance in trisomic children. Clin Exp Immunol1978; 33:298–301
  8. Trieu TV, Pontual LD. Conduite à tenir devant une diarrhée aiguë chez l’enfant. La presse médicale ; 2013, (42), 60-65. https://doi.org/10.1016/j.lpm.2012.10.012.
  9. Centers for Disease Control and Prevention ; 2016 . http : //www.cdc.gov/shigella/general-information.html
  10. Niyogi SK. Shigellosis. Journal of Microbiology . 2005; 43 (2): 133-143.
  11. Sangeetha AV, Parija SC, Mandal J., Krishnamurthy S. Profils cliniques et microbiologiques de la shigellose chez les enfants. Journal of Health, Population and Nutrition . 2014; 32 (4): 580-586.
  12. Sreenivasan S, Kali A, Pradeep J. Infection à Shigella flexneri multirésistante simulant une invagination intestinale. Journal of Laboratory Physicians . 2016; 8 (1): 55-57. doi: 10.4103 / 0974-2727.176225.
  13. Nylund CM, Denson LA, Noel JM. Entérite bactérienne comme facteur de risque pour l'invagination infantile: une étude de cohorte rétrospective. Journal of Pediatrics . 2010; 156 (5): 761–765. doi: 10.1016 / j.jpeds.2009.11.026.
  14. Lett DW, Marsh TD. Shigellosis in a newborn. American Journal of Perinatology. 1993; 10 (1): 58–59. doi: 10.1055 / s-2007-994703.
  15. Ghosh S, Pazhani GP, Chowdhury G. Genetic characteristics and changing antimicrobial resistance among Shigella spp. isolated from hospitalized diarrhoeal patients in Kolkata, India. Journal of Medical Microbiology. 2011;60(10):1460–1466. doi: 10.1099/jmm.0.032920-0.
  16. Sattar AS, Abbasi SA, Usman J, Faqir F, Kaleem F, Hanif F. Extended-spectrum β-lactamase production in Shigella flexneri. Journal of the College of Physicians and Surgeons Pakistan. 2010;20(11):768–769.
  17. Acikgoz ZC. Gulay Z, Bicmen M, Gocer S, Gamberzade S. CTX-M-3 extended-spectrum β-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scandinavian Journal of Infectious Diseases. 2003;35(8):503–505. doi: 10.1080/00365540310013270.
  18. Poirel L, Naas T, Nordmann P. Genetic support of extended-spectrum-lactamases. Clin Microbiol Infect 2008; 14:75-81.
  19. Decousser JW, Poirel L, Nordmann P. Characterization of a chromosomally encoded extended-spectrum class A -lactamase from Kluyvera cryocrescens. Antimicrob Agents Chemother 2001; 45:3595-8.
  20. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59:165-74.
  21. Parajuli NP, Joshi G, Pardhe BD, Shakya J, Bhetwal A., Shakya S, Khanal, PR. Shigellosis Caused by CTX-M Type ESBL Producing Shigella flexneri in Two Siblings of Rural Nepal: First Case Report from the Country. Case Reports in Infectious Diseases ; 2017, 1–5. doi: 10.1155 / 2017/1862320.
  22. Williams E, Lew TE, Fuller A, Spelman, DW, Jenney AW. Un cas de cholécystite aiguë et de gastro-entérite à Shigella sonnei produisant des BLSE multi-résistants chez un voyageur de retour. Journal of Travel Medicine ; (2018) ; 25 (1). doi: 10.1093 / jtm / tay029.